Wall Street analysts forecast that Sally Beauty Holdings, Inc. (NYSE:SBH) will report $995.66 million in sales for the current quarter, according to Zacks. Three analysts have issued estimates for Sally Beauty’s earnings, with the lowest sales estimate coming in at $985.60 million and the highest estimate coming in at $1.00 billion. Sally Beauty reported sales of $936.02 million in the same quarter last year, which indicates a positive year-over-year growth rate of 6.4{5c5ba01e4f28b4dd64874166358f62106ea5bcda869a94e59d702fa1c9707720}. The business is scheduled to report its next quarterly earnings report on Thursday, February 3rd.
On average, analysts expect that Sally Beauty will report full-year sales of $4.01 billion for the current year, with estimates ranging from $3.99 billion to $4.01 billion. For the next year, analysts expect that the firm will report sales of $4.07 billion, with estimates ranging from $4.04 billion to $4.11 billion. Zacks’ sales calculations are a mean average based on a survey of sell-side analysts that follow Sally Beauty.
Sally Beauty (NYSE:SBH) last released its earnings results on Thursday, November 11th. The specialty retailer reported $0.63 EPS for the quarter, topping analysts’ consensus estimates of $0.51 by $0.12. Sally Beauty had a return on equity of 148.76{5c5ba01e4f28b4dd64874166358f62106ea5bcda869a94e59d702fa1c9707720} and a net margin of 6.19{5c5ba01e4f28b4dd64874166358f62106ea5bcda869a94e59d702fa1c9707720}. The firm had revenue of $990.26 million for the quarter, compared to analysts’ expectations of $971.72 million. During the same period in the prior year, the firm posted $0.63 earnings per share.
A number of equities analysts have recently commented on SBH shares. Oppenheimer dropped their target price on Sally Beauty from $24.00 to $22.00 and set an “outperform” rating for the company in a report on Thursday, November 4th. Morgan Stanley boosted their price target on Sally Beauty from $22.00 to $23.00 and gave the stock an “equal weight” rating in a research report on Monday, November 15th. Finally, Zacks Investment Research raised Sally Beauty from a “hold” rating to a “strong-buy” rating and set a $24.00 price target for the company in a research report on Tuesday, November 16th. Three investment analysts have rated the stock with a hold rating, two have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus price target of $24.20.
There are 5.8 million people currently living with Alzheimer’s… Each patient is worth, on average, $27,672 a year.
This is why companies like this one are fighting so hard for a piece of your medicine cabinet.
This gives investors like you a huge opportunity.
Shares of NYSE:SBH opened at $18.13 on Friday. The stock’s 50-day simple moving average is $19.39 and its two-hundred day simple moving average is $18.68. The company has a debt-to-equity ratio of 4.92, a quick ratio of 0.77 and a current ratio of 2.08. Sally Beauty has a 52-week low of $13.20 and a 52-week high of $25.66. The stock has a market capitalization of $2.05 billion, a price-to-earnings ratio of 8.67 and a beta of 1.46.
In other Sally Beauty news, Director Susan R. Mulder sold 5,000 shares of the business’s stock in a transaction on Friday, November 26th. The stock was sold at an average price of $20.14, for a total value of $100,700.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Susan R. Mulder sold 2,901 shares of the company’s stock in a transaction on Thursday, December 9th. The stock was sold at an average price of $21.00, for a total value of $60,921.00. The disclosure for this sale can be found here. In the last three months, insiders have sold 15,401 shares of company stock worth $319,171. Corporate insiders own 1.74{5c5ba01e4f28b4dd64874166358f62106ea5bcda869a94e59d702fa1c9707720} of the company’s stock.
A number of institutional investors and hedge funds have recently added to or reduced their stakes in SBH. Millennium Management LLC boosted its holdings in shares of Sally Beauty by 302.9{5c5ba01e4f28b4dd64874166358f62106ea5bcda869a94e59d702fa1c9707720} in the third quarter. Millennium Management LLC now owns 763,107 shares of the specialty retailer’s stock valued at $12,858,000 after acquiring an additional 573,719 shares in the last quarter. Foundry Partners LLC acquired a new position in Sally Beauty in the 3rd quarter worth approximately $9,662,000. Principal Financial Group Inc. lifted its position in Sally Beauty by 19.7{5c5ba01e4f28b4dd64874166358f62106ea5bcda869a94e59d702fa1c9707720} in the 2nd quarter. Principal Financial Group Inc. now owns 2,855,842 shares of the specialty retailer’s stock worth $63,028,000 after buying an additional 470,115 shares in the last quarter. Arrowstreet Capital Limited Partnership lifted its position in Sally Beauty by 33.3{5c5ba01e4f28b4dd64874166358f62106ea5bcda869a94e59d702fa1c9707720} in the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 1,773,613 shares of the specialty retailer’s stock worth $29,885,000 after buying an additional 443,239 shares in the last quarter. Finally, ArrowMark Colorado Holdings LLC raised its holdings in shares of Sally Beauty by 2.9{5c5ba01e4f28b4dd64874166358f62106ea5bcda869a94e59d702fa1c9707720} during the 3rd quarter. ArrowMark Colorado Holdings LLC now owns 15,406,794 shares of the specialty retailer’s stock valued at $259,604,000 after purchasing an additional 432,093 shares in the last quarter.
About Sally Beauty
Sally Beauty Holdings, Inc is an international retailer and distributor of professional beauty supplies. It operates through the Sally Beauty Supply (SBS) and Beauty Systems Group (BSG) segments. The SBS segment offers domestic and international chain of retail stores and a consumer-facing e-commerce website that offers professional beauty supplies to both salon professionals and retail customers primarily in North America, Puerto Rico, and parts of Europe and South America.
Featured Story: Most Volatile Stocks
Get a free copy of the Zacks research report on Sally Beauty (SBH)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]
Should you invest $1,000 in Sally Beauty right now?
Before you consider Sally Beauty, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Sally Beauty wasn’t on the list.
While Sally Beauty currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.
View The 5 Stocks Here
